Oragenics (OGEN) Earnings Date & Reports

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

OGEN is expected to report earnings to fall 95.05% to -5 cents per share on May 15

Q1'23

Est.

$-0.05

Q4'22

Beat

by $1.39

Q3'22

Beat

by $0.02

Q2'22

Beat

by $0.01

Q1'22

Missed

by $0.03

The last earnings report on February 17 showed earnings per share of -100 cents, beating the estimate of -240 cents. With 583.85K shares outstanding, the current market capitalization sits at 4.29M.

View a ticker or compare two or three

Compare

OGEN